D. Gully et al., EFFECT OF THE NEUROTENSIN RECEPTOR ANTAGONIST SR48692 ON RAT-BLOOD PRESSURE MODULATION BY NEUROTENSIN, Life sciences, 58(8), 1996, pp. 665-674
Citations number
24
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
When administered as an intravenous injection in the pentobarbitone-an
aesthetized rat, neurotensin (NT) elicits a biphasic depressor-presser
effect that can be evaluated by the mean arterial blood pressure (MAB
P). The first hypotensive phase elicited by low doses of NT is depende
nt on the interaction of NT with its specific receptors and may be med
iated by the release of histamine, since it is prevented by oral pretr
eatment with the selective NT receptor antagonist SR 48692 and by intr
avenous pretreatment with a selective H-1 receptor antagonist mepyrami
ne. The hypertensive effect evoked by higher doses of NT is histamine-
independent but remains NT receptor-mediated. The prevention of the bi
phasic effect on MABP by oral administration of the NT receptor antago
nist SR 48692 validates the implication of NT receptors in the histami
ne release phenomenon.